TABLE 3.
EP CTX (14 weeks of gestation) | LP CTX2 (34 weeks of gestation) | Δ CTX2,3 | |||||||
---|---|---|---|---|---|---|---|---|---|
Exposure | n | β4 (95% CI) | P value | n | β4 (95% CI) | P value | n | β (95% CI) | P value |
Maternal age, y | 493 | −0.03 (−0.05, −0.01) | <0.001 | 469 | −0.03 (−0.04, −0.01) | 0.01 | 372 | −0.02 (−0.037, 0.002) | 0.07 |
Strenuous exercise >1 h/wk (Y/N) | 440 | −0.10 (−0.36, 0.16) | 0.47 | 425 | −0.11 (−0.40, 0.18) | 0.47 | 329 | −0.17 (−0.50, 0.16) | 0.31 |
Smoking in early pregnancy (Y/N) | 491 | 0.36 (0.05, 0.68) | 0.03 | 467 | −0.20 (−0.53, 0.13) | 0.24 | 370 | −0.20 (−0.57, 0.17) | 0.30 |
Parity ≥1 (Y/N) | 491 | −0.48 (−0.66, −0.31) | <0.001 | 467 | −0.33 (−0.52, −0.15) | <0.001 | 371 | −0.11 (−0.32, 0.09) | 0.28 |
Caucasian ethnicity (Y/N) | 490 | 0.17 (−0.25, 0.58) | 0.44 | 466 | 0.23 (−0.21, 0.67) | 0.31 | 369 | 0.33 (−0.20, 0.86) | 0.22 |
Weight, kg | 493 | −0.01 (−0.01, 0.00) | 0.07 | 469 | 0.002 (−0.004, 0.008) | 0.50 | 372 | 0.01 (−0.001, 0.013) | 0.12 |
Height, cm | 488 | −0.01 (−0.03, 0.00) | 0.05 | 465 | −0.02 (−0.03, −0.01) | 0.004 | 368 | −0.01 (−0.029, 0.004) | 0.13 |
BMI, kg/cm2 | 488 | −0.01 (−0.03, 0.01) | 0.21 | 465 | 0.02 (−0.001, 0.034) | 0.07 | 368 | 0.02 (0.001, 0.041) | 0.04 |
14-wk 25(OH)D, nmol/L | 488 | 0.004 (−0.001, 0.009) | 0.14 | 496 | −0.004 (−0.010, 0.001) | 0.13 | 371 | −0.01 (−0.014, −0.001) | 0.03 |
14-wk calcium, mmol/L | 488 | 0.53 (−0.56, 1.62) | 0.34 | 496 | 0.67 (−0.36, 1.70) | 0.20 | 371 | 1.14 (−0.09, 2.38) | 0.07 |
34-wk 25(OH)D, nmol/L | 489 | −0.001 (−0.016, 0.003) | 0.55 | 364 | −0.003 (−0.009, 0.002) | 0.19 | |||
34-wk calcium, mmol/L | 488 | 0.15 (−0.63, 0.92) | 0.71 | 363 | 0.19 (−0.74, 1.11) | 0.70 | |||
Change in 25(OH)D from 14 to 34 wk, nmol/L | 487 | 0.001 (−0.003, 0.005) | 0.60 | 363 | 0.001 (−0.004, 0.006) | 0.77 | |||
Vitamin D–supplemented group (Y/N) | 498 | −0.18 (−0.35, −0.00) | 0.05 | 372 | −0.32 (−0.52, −0.11) | 0.002 | |||
Season of delivery, summer (proxy for season of measurement) | 438 | 0.02 (−0.16, 0.21) | 0.81 | 488 | 0.07 (−0.11, 0.25) | 0.44 | 366 | 0.07 (−0.14, 0.27) | 0.52 |
CTX, C-terminal telopeptide of type I collagen; EP, early pregnancy; LP, late pregnancy; 25(OH)D, 25-hydroxyvitamin D.
SD change in urinary CTX (Fisher-Yates score) per unit exposure.
Adjusted for treatment group, except when associations between the vitamin D–supplemented group and CTX were being tested.
Conditional change in CTX (LP CTX adjusted for EP CTX), as z score.